Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1

Conditions

Lymphoma 53Lymphoma, Non-Hodgkin 36Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Follicular 28Lymphoma, Mantle-Cell 26Glioblastoma 25Central Nervous System Neoplasms 25Hodgkin Disease 22Gliosarcoma 21Astrocytoma 21Lymphoma, Large-Cell, Immunoblastic 20Brain Neoplasms 20Burkitt Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Multiple Myeloma 15Glioma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Oligodendroglioma 12Lymphoma, B-Cell, Marginal Zone 11Leukemia 10Neoplasms, Plasma Cell 9Recurrence 7Lymphoma, B-Cell 5Waldenstrom Macroglobulinemia 4Medulloblastoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, T-Cell 4Leukemia, Myeloid, Acute 4Ependymoma 4Lymphoma, Large-Cell, Anaplastic 3

Interventions

fludarabine phosphate 6Whole-Body Irradiation 5Mycophenolic Acid 5Peripheral Blood Stem Cell Transplantation 4Cyclosporins 4Cyclosporine 4Cyclophosphamide 3Alemtuzumab 3fludarabine 2carmustine, poliferprosan 20 drug combination 2Stem Cell Transplantation 2Sirolimus 2Melphalan 2Etoposide 2Cytarabine 2Carmustine 2venetoclax 1thymoglobulin 1romidepsin 1niraparib 1nelarabine 1letermovir 1itacitinib 1ibrutinib 1Tacrolimus 1Mitoxantrone 1Interleukin-15 1INCB039110 1Hematopoietic Stem Cell Transplantation 1GRN163L peptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Prolymphocytic, T-Cell × Carmustine × Clear all
NCT00005803 2020-01-29

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Fred Hutchinson Cancer Center

Phase 1/2 Completed
76 enrolled 11 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic

NCT01008462 2019-06-11

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
16 enrolled 15 charts
LymphoidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡